02627.HK
Ab&B Bio Tech Co Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 29.32
−1.01%Margins
Gross margin
70.6%
EBITDA margin
-292.9%
EBIT margin
-322.5%
Net margin
-355.1%
FCF margin
-420.2%
-752.1%
Return on equity
-17.4%
Return on assets
-23.8%
Return on invested capital
0.05x
Asset turnover
-HKD 162.9M
Cash from operations
HKD 0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025